HK Stock Market Move | SMOORE INTL(06969) jumped more than 6%, with mid-term performance disclosure coming soon and institutions optimistic about Glo Hilo's subsequent volume increase.
SJM Holdings (06969) rose more than 6%, as of the time of writing, it rose by 6.29% to HK$21.64, with a turnover of HK$5.01 billion.
SMOORE INTL (06969) rose by more than 6%, with a gain of 6.29% at the time of publication, reaching HK$21.64, with a turnover of HK$5.01 billion.
On the news front, SMOORE INTL will hold a board meeting today to consider and approve the interim performance for the six months ending on June 30, 2025, and to declare an interim dividend (if any). SMOORE INTL previously announced that it expects to achieve revenue of HK$6.013 billion in the first half of 2025, an increase of 18% year-on-year; and expects a profit before tax of approximately HK$629 million to HK$769 million, a decrease of 5% to 23% year-on-year. The decrease in profit is mainly due to an increase of RMB 176 million in non-cash share-based payment expenses, distribution and sales expenses, and significant growth in legal services related expenses.
UBS previously pointed out that preliminary performance data shows an 18% year-on-year growth in revenue in the first half, attributed to the recovery of the Vape business and increased shipments in advance of the US tariffs. The company is expected to see a decrease in net profit of 21% to 35% in the second half, mainly due to high expenditures related to stock options granted in the fourth quarter and S&D. Zheshang believes that British American Tobacco has made significant efforts in resources and marketing input in Glo Hilo, with positive feedback from trial sales in Japan and early deployment in some European countries, anticipating future volume growth. In addition, oral tobacco products maintain rapid growth, while atomized tobacco is expected to recover under the crackdown on illegal tobacco, showing continued optimism for the core supplier SMOORE INTL.
Related Articles

KINGSOFT CLOUD (KC.US, 03896.HK) Q2 revenue growth accelerated again AI revenue increased by over 120% year on year to 730 million yuan

MAXNERVA TECH (01037) releases its interim results, with a net loss of 2.375 million yuan, representing a year-on-year reduction of 85.3%.

Jiangsu Hengrui Pharmaceuticals (600276.SH) plans to spend 1 to 2 billion yuan to implement a repurchase, with a repurchase price not exceeding 90.85 yuan per share.
KINGSOFT CLOUD (KC.US, 03896.HK) Q2 revenue growth accelerated again AI revenue increased by over 120% year on year to 730 million yuan

MAXNERVA TECH (01037) releases its interim results, with a net loss of 2.375 million yuan, representing a year-on-year reduction of 85.3%.

Jiangsu Hengrui Pharmaceuticals (600276.SH) plans to spend 1 to 2 billion yuan to implement a repurchase, with a repurchase price not exceeding 90.85 yuan per share.
